Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Vistagen Therapeutics (VTGN) Other Operating Expenses (2020)

Historic Other Operating Expenses for Vistagen Therapeutics (VTGN) over the last 3 years, with Q2 2020 value amounting to $200.0.

  • Vistagen Therapeutics' Other Operating Expenses changed N/A to $200.0 in Q2 2020 from the same period last year, while for Mar 2021 it was $200.0, marking a year-over-year change of. This contributed to the annual value of -$200.0 for FY2013, which is N/A changed from last year.
  • Latest data reveals that Vistagen Therapeutics reported Other Operating Expenses of $200.0 as of Q2 2020.
  • In the past 5 years, Vistagen Therapeutics' Other Operating Expenses registered a high of $200.0 during Q2 2020, and its lowest value of $200.0 during Q2 2020.